Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Psychol Med

Retrieve available abstracts of 333 articles:
HTML format

Single Articles

    July 2021
  1. WIESSNER I, Falchi M, Palhano-Fontes F, Feilding A, et al
    LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
    Psychol Med. 2021 Jul 13:1-15. doi: 10.1017/S0033291721002531.
    PubMed     Abstract available

  2. JOHNSON EC, Kapoor M, Hatoum AS, Zhou H, et al
    Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder.
    Psychol Med. 2021 Jul 7:1-9. doi: 10.1017/S003329172100266.
    PubMed     Abstract available

    June 2021
  3. CZEPIELEWSKI LS, Alliende LM, Castaneda CP, Castro M, et al
    Effects of socioeconomic status in cognition of people with schizophrenia: results from a Latin American collaboration network with 1175 subjects.
    Psychol Med. 2021 Jun 23:1-12. doi: 10.1017/S0033291721002403.
    PubMed     Abstract available

  4. SCHOFIELD P, Das-Munshi J, Webb RT, Horsdal HT, et al
    Lack of fit with the neighbourhood social environment as a risk factor for psychosis - a national cohort study.
    Psychol Med. 2021 Jun 18:1-9. doi: 10.1017/S0033291721002233.
    PubMed     Abstract available

  5. STRAUSS GP, Bartolomeo LA, Luther L
    Reduced willingness to expend effort for rewards is associated with risk for conversion and negative symptom severity in youth at clinical high-risk for psychosis.
    Psychol Med. 2021 Jun 14:1-8. doi: 10.1017/S003329172100204.
    PubMed     Abstract available

  6. DONG D, Yao D, Wang Y, Hong SJ, et al
    Compressed sensorimotor-to-transmodal hierarchical organization in schizophrenia.
    Psychol Med. 2021 Jun 8:1-14. doi: 10.1017/S0033291721002129.
    PubMed     Abstract available

    May 2021
  7. STAFFORD J, Dykxhoorn J, Sommerlad A, Dalman C, et al
    Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study.
    Psychol Med. 2021 May 25:1-9. doi: 10.1017/S0033291721002099.
    PubMed     Abstract available

  8. O'DONOGHUE B, Lyne J, Roche E, Mifsud N, et al
    Risk of first-episode psychosis in migrants to the Republic of Ireland.
    Psychol Med. 2021 May 25:1-8. doi: 10.1017/S003329172100177.
    PubMed     Abstract available

  9. LINDGREN M, Kuvaja H, Jokela M, Therman S, et al
    Predictive validity of psychosis risk models when applied to adolescent psychiatric patients.
    Psychol Med. 2021 May 24:1-12. doi: 10.1017/S0033291721001938.
    PubMed     Abstract available

  10. AYESA-ARRIOLA R, Miguel-Corredera M, de la Foz VO, Neergaard KD, et al
    Education and long-term outcomes in first episode psychosis: 10-year follow-up study of the PAFIP cohort.
    Psychol Med. 2021 May 6:1-12. doi: 10.1017/S0033291721001112.
    PubMed     Abstract available

    April 2021
  11. ZHANG R, Kuja-Halkola R, Birgegard A, Larsson H, et al
    Association of family history of schizophrenia and clinical outcomes in individuals with eating disorders.
    Psychol Med. 2021 Apr 30:1-8. doi: 10.1017/S0033291721001574.
    PubMed     Abstract available

  12. MCHUGO M, Avery S, Armstrong K, Rogers BP, et al
    Anterior hippocampal dysfunction in early psychosis: a 2-year follow-up study.
    Psychol Med. 2021 Apr 20:1-10. doi: 10.1017/S0033291721001318.
    PubMed     Abstract available

  13. SEDGWICK O, Hardy A, Newbery K, Cella M, et al
    A systematic review of adherence to group interventions in psychosis: do people attend?
    Psychol Med. 2021 Apr 16:1-9. doi: 10.1017/S0033291721000404.
    PubMed     Abstract available

  14. JOO SW, Kim H, Jo YT, Choi YJ, et al
    Antipsychotic treatment and risk of discontinuation and hospitalization in first-episode schizophrenia: a nationwide population-based study.
    Psychol Med. 2021 Apr 15:1-8. doi: 10.1017/S0033291721001379.
    PubMed     Abstract available

  15. SWERDLOW NR, Bhakta SG, Talledo J, Benster L, et al
    Auditory discrimination and frequency modulation learning in schizophrenia patients: amphetamine within-subject dose response and time course.
    Psychol Med. 2021 Apr 14:1-9. doi: 10.1017/S0033291721001239.
    PubMed     Abstract available

    March 2021
  16. CORSI-ZUELLI F, Marques L, da Roza DL, Loureiro CM, et al
    The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis.
    Psychol Med. 2021 Mar 19:1-11. doi: 10.1017/S0033291721000726.
    PubMed     Abstract available

  17. HARPER J, Liu M, Malone SM, McGue M, et al
    Using multivariate endophenotypes to identify psychophysiological mechanisms associated with polygenic scores for substance use, schizophrenia, and education attainment.
    Psychol Med. 2021 Mar 18:1-11. doi: 10.1017/S0033291721000763.
    PubMed     Abstract available

  18. DENG F, Phillips MR, Cai B, Yu G, et al
    Comparison of social cognition using an adapted Chinese version of the Reading the Mind in the Eyes Test in drug-naive and regularly medicated individuals with chronic schizophrenia and healthy controls in rural China.
    Psychol Med. 2021 Mar 16:1-13. doi: 10.1017/S003329172100043.
    PubMed     Abstract available

  19. FRYER SL, Ferri JM, Roach BJ, Loewy RL, et al
    Thalamic dysconnectivity in the psychosis risk syndrome and early illness schizophrenia.
    Psychol Med. 2021 Mar 15:1-9. doi: 10.1017/S0033291720004882.
    PubMed     Abstract available

  20. TAN EJ, Rossell SL, Subotnik KL, Ventura J, et al
    Cognitive heterogeneity in first-episode psychosis and its relationship with premorbid developmental adjustment.
    Psychol Med. 2021 Mar 12:1-10. doi: 10.1017/S0033291721000738.
    PubMed     Abstract available

  21. WORTINGER LA, Jorgensen KN, Barth C, Nerland S, et al
    Significant association between intracranial volume and verbal intellectual abilities in patients with schizophrenia and a history of birth asphyxia.
    Psychol Med. 2021 Mar 10:1-10. doi: 10.1017/S0033291721000489.
    PubMed     Abstract available

  22. CHEN KC, Yang YK, Howes OD, Lee IH, et al
    Striatal dopamine D2/3 receptors in medication-naive schizophrenia: an [(123)I] IBZM SPECT study.
    Psychol Med. 2021 Mar 8:1-9. doi: 10.1017/S0033291720005413.
    PubMed     Abstract available

  23. KLIPPEL A, Schick A, Myin-Germeys I, Rauschenberg C, et al
    Modelling the temporal interplay between stress and affective disturbances in pathways to psychosis: an experience sampling study.
    Psychol Med. 2021 Mar 8:1-10. doi: 10.1017/S0033291720004894.
    PubMed     Abstract available

  24. GAULD C, Micoulaud-Franchi JA, Dumas G
    Comment on Starke et al.: "Computing schizophrenia: ethical challenges for machine learning in psychiatry": From machine learning to student learning: pedagogical challenges for psychiatry - Corrigendum.
    Psychol Med. 2021 Mar 4:1. doi: 10.1017/S0033291721000684.

  25. CAKICI N, Sutterland AL, Penninx BWJH, de Haan L, et al
    Changes in peripheral blood compounds following psychopharmacological treatment in drug-naive first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
    Psychol Med. 2021 Mar 3:1-12. doi: 10.1017/S0033291721000155.
    PubMed     Abstract available

  26. MISRA S, Gelaye B, Williams DR, Koenen KC, et al
    Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study.
    Psychol Med. 2021 Mar 2:1-9. doi: 10.1017/S0033291721000453.
    PubMed     Abstract available

    February 2021
  27. HUANG LY, Jackson BS, Rodrigue AL, Tamminga CA, et al
    Antisaccade error rates and gap effects in psychosis syndromes from bipolar-schizophrenia network for intermediate phenotypes 2 (B-SNIP2).
    Psychol Med. 2021 Feb 24:1-10. doi: 10.1017/S003329172000478.
    PubMed     Abstract available

  28. GRIFFITHS K, Millgate E, Egerton A, MacCabe JH, et al
    Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2021 Feb 19:1-11. doi: 10.1017/S0033291721000246.
    PubMed     Abstract available

  29. ZHANG T, Xu L, Li H, Cui H, et al
    Individualized risk components guiding antipsychotic delivery in patients with a clinical high risk of psychosis: application of a risk calculator.
    Psychol Med. 2021 Feb 17:1-10. doi: 10.1017/S0033291721000064.
    PubMed     Abstract available

  30. PIAO YH, Yun JY, Nguyen TB, Kim WS, et al
    Longitudinal symptom network structure in first-episode psychosis: a possible marker for remission.
    Psychol Med. 2021 Feb 16:1-9. doi: 10.1017/S0033291720005280.
    PubMed     Abstract available

  31. MA CF, Chan SKW, Chung YL, Ng SM, et al
    The predictive power of expressed emotion and its components in relapse of schizophrenia: a meta-analysis and meta-regression.
    Psychol Med. 2021 Feb 11:1-11. doi: 10.1017/S0033291721000209.
    PubMed     Abstract available

  32. TARRICONE I, D'Andrea G, Jongsma HE, Tosato S, et al
    Migration history and risk of psychosis: results from the multinational EU-GEI study.
    Psychol Med. 2021 Feb 10:1-13. doi: 10.1017/S003329172000495.
    PubMed     Abstract available

  33. LEGGE SE, Santoro ML, Periyasamy S, Okewole A, et al
    Genetic architecture of schizophrenia: a review of major advancements.
    Psychol Med. 2021 Feb 8:1-10. doi: 10.1017/S0033291720005334.
    PubMed     Abstract available

  34. HARROW M, Jobe TH, Tong L
    Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders.
    Psychol Med. 2021 Feb 8:1-11. doi: 10.1017/S0033291720004778.
    PubMed     Abstract available

  35. SIAFIS S, Davis JM, Leucht S
    Antipsychotic drugs: from 'major tranquilizers' to Neuroscience-based-Nomenclature.
    Psychol Med. 2021;51:522-524.

  36. MONCRIEFF J, Cohen D
    Antipsychotics as particular types of sedatives.
    Psychol Med. 2021;51:521.

    January 2021
  37. RINGIN E, Cropley V, Zalesky A, Bruggemann J, et al
    The impact of smoking status on cognition and brain morphology in schizophrenia spectrum disorders.
    Psychol Med. 2021 Jan 14:1-19. doi: 10.1017/S0033291720005152.
    PubMed     Abstract available

  38. LIU N, Lencer R, Yang Z, Zhang W, et al
    Altered functional synchrony between gray and white matter as a novel indicator of brain system dysconnectivity in schizophrenia.
    Psychol Med. 2021 Jan 13:1-9. doi: 10.1017/S0033291720004420.
    PubMed     Abstract available

    The social defeat hypothesis of schizophrenia is more topical than ever. Reply to Schalbroeck.
    Psychol Med. 2021 Jan 12:1-2. doi: 10.1017/S0033291720005176.

  40. MEYER N, Joyce DW, Karr C, de Vos M, et al
    The temporal dynamics of sleep disturbance and psychopathology in psychosis: a digital sampling study.
    Psychol Med. 2021 Jan 12:1-10. doi: 10.1017/S0033291720004857.
    PubMed     Abstract available

  41. MOORE TM, Calkins ME, Rosen AFG, Butler ER, et al
    Development of a probability calculator for psychosis risk in children, adolescents, and young adults.
    Psychol Med. 2021 Jan 12:1-9. doi: 10.1017/S0033291720005231.
    PubMed     Abstract available

    December 2020
  42. BERGE D, Lesh TA, Smucny J, Carter CS, et al
    Improvement in prefrontal thalamic connectivity during the early course of the illness in recent-onset psychosis: a 12-month longitudinal follow-up resting-state fMRI study.
    Psychol Med. 2020 Dec 16:1-9. doi: 10.1017/S0033291720004808.
    PubMed     Abstract available

  43. LEE TY, Hwang WJ, Kim NS, Park I, et al
    Prediction of psychosis: model development and internal validation of a personalized risk calculator.
    Psychol Med. 2020 Dec 14:1-9. doi: 10.1017/S0033291720004675.
    PubMed     Abstract available

    Listening to our critics; the care of people with psychosis.
    Psychol Med. 2020 Dec 7:1-2. doi: 10.1017/S0033291720004341.

    November 2020
  45. SARPAL DK, Tarcijonas G, Calabro FJ, Foran W, et al
    Context-specific abnormalities of the central executive network in first-episode psychosis: relationship with cognition.
    Psychol Med. 2020 Nov 23:1-10. doi: 10.1017/S0033291720004201.
    PubMed     Abstract available

  46. FAN F, Tan S, Huang J, Chen S, et al
    Functional disconnection between subsystems of the default mode network in schizophrenia.
    Psychol Med. 2020 Nov 13:1-11. doi: 10.1017/S003329172000416.
    PubMed     Abstract available

  47. GUIMOND S, Ling G, Drodge J, Matheson H, et al
    Functional connectivity associated with improvement in emotion management after cognitive enhancement therapy in early-course schizophrenia.
    Psychol Med. 2020 Nov 13:1-10. doi: 10.1017/S0033291720004110.
    PubMed     Abstract available

    The social defeat hypothesis of schizophrenia: a parsimonious explanation for multiple psychosis risk factors?
    Psychol Med. 2020 Nov 10:1-2. doi: 10.1017/S0033291720004092.

    October 2020
  49. CHRISTOPHE G, Jean-Arthur MF, Guillaume D
    Comment on Starke et al.: 'Computing schizophrenia: ethical challenges for machine learning in psychiatry': from machine learning to student learning: pedagogical challenges for psychiatry.
    Psychol Med. 2020 Oct 22:1-3. doi: 10.1017/S0033291720003906.

  50. VAN OS J, Pries LK, Ten Have M, de Graaf R, et al
    Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway.
    Psychol Med. 2020 Oct 19:1-13. doi: 10.1017/S0033291720003748.
    PubMed     Abstract available

  51. LOPEZ-MORINIGO JD, Ajnakina O, Martinez AS, Escobedo-Aedo PJ, et al
    Can metacognitive interventions improve insight in schizophrenia spectrum disorders? A systematic review and meta-analysis.
    Psychol Med. 2020 Oct 14:1-13. doi: 10.1017/S0033291720003384.
    PubMed     Abstract available

  52. HENQUET C, van Os J, Pries LK, Rauschenberg C, et al
    A replication study of JTC bias, genetic liability for psychosis and delusional ideation.
    Psychol Med. 2020 Oct 13:1-7. doi: 10.1017/S0033291720003578.
    PubMed     Abstract available

  53. BRIDGWATER M, Bachman P, Tervo-Clemmens B, Haas G, et al
    Developmental influences on symptom expression in antipsychotic-naive first-episode psychosis.
    Psychol Med. 2020 Oct 6:1-12. doi: 10.1017/S0033291720003463.
    PubMed     Abstract available

  54. CATALAN A, Tognin S, Kempton MJ, Stahl D, et al
    Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis.
    Psychol Med. 2020 Oct 6:1-9. doi: 10.1017/S0033291720003396.
    PubMed     Abstract available

    September 2020
  55. IYER SN, Malla A, Taksal A, Maraj A, et al
    Context and contact: a comparison of patient and family engagement with early intervention services for psychosis in India and Canada.
    Psychol Med. 2020 Sep 28:1-10. doi: 10.1017/S0033291720003359.
    PubMed     Abstract available

  56. NUECHTERLEIN KH, Ventura J, Subotnik KL, Gretchen-Doorly D, et al
    A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning.
    Psychol Med. 2020 Sep 28:1-10. doi: 10.1017/S0033291720003335.
    PubMed     Abstract available

  57. NEWBURY JB, Arseneault L, Caspi A, Moffitt TE, et al
    Association between genetic and socioenvironmental risk for schizophrenia during upbringing in a UK longitudinal cohort.
    Psychol Med. 2020 Sep 25:1-11. doi: 10.1017/S0033291720003347.
    PubMed     Abstract available

  58. EHRMINGER M, Roux P, Urbach M, Andre M, et al
    The puzzle of quality of life in schizophrenia: putting the pieces together with the FACE-SZ cohort.
    Psychol Med. 2020 Sep 23:1-8. doi: 10.1017/S0033291720003311.
    PubMed     Abstract available

  59. PERALTA V, Cuesta MJ
    Schneider's first-rank symptoms have neither diagnostic value for schizophrenia nor higher clinical validity than other delusions and hallucinations in psychotic disorders.
    Psychol Med. 2020 Sep 18:1-4. doi: 10.1017/S0033291720003293.
    PubMed     Abstract available

  60. AMORETTI S, Rosa AR, Mezquida G, Cabrera B, et al
    The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses.
    Psychol Med. 2020 Sep 9:1-12. doi: 10.1017/S0033291720002226.
    PubMed     Abstract available

  61. MURRAY RM, David AS, Ajnakina O
    Prevention of psychosis: moving on from the at-risk mental state to universal primary prevention.
    Psychol Med. 2020 Sep 7:1-5. doi: 10.1017/S003329172000313.
    PubMed     Abstract available

  62. JONGSMA HE, Gayer-Anderson C, van der Ven E, Quattrone D, et al
    Authors' reply to 'on the existence of a linguistic distance in schizophrenia'.
    Psychol Med. 2020 Sep 3:1-2. doi: 10.1017/S0033291720003013.

  63. PRASAD KM, Gertler J, Tollefson S, Wood JA, et al
    Heritable anisotropy associated with cognitive impairments among patients with schizophrenia and their non-psychotic relatives in multiplex families.
    Psychol Med. 2020 Sep 3:1-12. doi: 10.1017/S0033291720002883.
    PubMed     Abstract available

  64. JIANG Y, Yao D, Zhou J, Tan Y, et al
    Characteristics of disrupted topological organization in white matter functional connectome in schizophrenia.
    Psychol Med. 2020 Sep 3:1-11. doi: 10.1017/S0033291720003141.
    PubMed     Abstract available

    August 2020
  65. THUAIRE F, Rondepierre F, Vallet GT, Jalenques I, et al
    Executive deficits in schizophrenia: mediation by processing speed and its relationships with aging.
    Psychol Med. 2020 Aug 25:1-9. doi: 10.1017/S0033291720002871.
    PubMed     Abstract available

  66. MORAN EK, Gold JM, Carter CS, MacDonald AW, et al
    Both unmedicated and medicated individuals with schizophrenia show impairments across a wide array of cognitive and reinforcement learning tasks.
    Psychol Med. 2020 Aug 17:1-11. doi: 10.1017/S003329172000286.
    PubMed     Abstract available

  67. LEMVIGH CK, Brouwer RM, Pantelis C, Jensen MH, et al
    Heritability of specific cognitive functions and associations with schizophrenia spectrum disorders using CANTAB: a nation-wide twin study.
    Psychol Med. 2020 Aug 11:1-14. doi: 10.1017/S0033291720002858.
    PubMed     Abstract available

  68. WORTINGER LA, Engen K, Barth C, Andreassen OA, et al
    Asphyxia at birth affects brain structure in patients on the schizophrenia-bipolar disorder spectrum and healthy participants.
    Psychol Med. 2020 Aug 10:1-10. doi: 10.1017/S0033291720002779.
    PubMed     Abstract available

  69. NENADIC I, Meller T, Schmitt S, Stein F, et al
    Polygenic risk for schizophrenia and schizotypal traits in non-clinical subjects.
    Psychol Med. 2020 Aug 6:1-11. doi: 10.1017/S0033291720002822.
    PubMed     Abstract available

  70. ALAMEDA L, Rodriguez V, Carr E, Aas M, et al
    A systematic review on mediators between adversity and psychosis: potential targets for treatment.
    Psychol Med. 2020 Aug 3:1-11. doi: 10.1017/S0033291720002421.
    PubMed     Abstract available

    July 2020
  71. ALHERZ M
    On the existence of a linguistic distance in schizophrenia.
    Psychol Med. 2020 Jul 23:1-2. doi: 10.1017/S0033291720002585.

  72. RODRIGUEZ-SANCHEZ JM, Setien-Suero E, Suarez-Pinilla P, Mayoral Van Son J, et al
    Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort.
    Psychol Med. 2020 Jul 20:1-10. doi: 10.1017/S0033291720002408.
    PubMed     Abstract available

  73. DICKSON H, Hedges EP, Ma SY, Cullen AE, et al
    Academic achievement and schizophrenia: a systematic meta-analysis.
    Psychol Med. 2020 Jul 20:1-17. doi: 10.1017/S0033291720002354.
    PubMed     Abstract available

  74. SIDELI L, Murray RM, Schimmenti A, Corso M, et al
    Childhood adversity and psychosis: a systematic review of bio-psycho-social mediators and moderators.
    Psychol Med. 2020 Jul 6:1-22. doi: 10.1017/S0033291720002172.
    PubMed     Abstract available

    June 2020
  75. MELLER T, Schmitt S, Ettinger U, Grant P, et al
    Brain structural correlates of schizotypal signs and subclinical schizophrenia nuclear symptoms in healthy individuals.
    Psychol Med. 2020 Jun 24:1-10. doi: 10.1017/S0033291720002044.
    PubMed     Abstract available

  76. LYNHAM AJ, Cleaver SL, Jones IR, Walters JTR, et al
    A meta-analysis comparing cognitive function across the mood/psychosis diagnostic spectrum.
    Psychol Med. 2020 Jun 22:1-9. doi: 10.1017/S0033291720002020.
    PubMed     Abstract available

  77. STARKE G, De Clercq E, Borgwardt S, Elger BS, et al
    Computing schizophrenia: ethical challenges for machine learning in psychiatry.
    Psychol Med. 2020 Jun 15:1-7. doi: 10.1017/S0033291720001683.
    PubMed     Abstract available

    A major flaw in the diagnosis of schizophrenia: what happened to the Schneider's first rank symptoms.
    Psychol Med. 2020 Jun 11:1-9. doi: 10.1017/S0033291720001816.
    PubMed     Abstract available

  79. JONES HJ, Hammerton G, McCloud T, Hines LA, et al
    Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence.
    Psychol Med. 2020 Jun 9:1-8. doi: 10.1017/S0033291720001798.
    PubMed     Abstract available

  80. PATEL GH, Arkin SC, Ruiz-Betancourt DR, DeBaun HM, et al
    What you see is what you get: visual scanning failures of naturalistic social scenes in schizophrenia.
    Psychol Med. 2020 Jun 5:1-10. doi: 10.1017/S0033291720001646.
    PubMed     Abstract available

  81. BORA E
    Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis - CORRIGENDUM.
    Psychol Med. 2020 Jun 2:1. doi: 10.1017/S0033291720001701.

    May 2020
  82. LAVALLE L, Donde C, Gaweda L, Brunelin J, et al
    Impaired self-recognition in individuals with no full-blown psychotic symptoms represented across the continuum of psychosis: a meta-analysis.
    Psychol Med. 2020 May 29:1-11. doi: 10.1017/S003329172000152.
    PubMed     Abstract available

  83. VERDOUX H, Quiles C, Bon L, Chereau-Boudet I, et al
    Impact of anticholinergic load on functioning and cognitive performances of persons with psychosis referred to psychosocial rehabilitation centers.
    Psychol Med. 2020 May 22:1-9. doi: 10.1017/S0033291720001403.
    PubMed     Abstract available

  84. HERMANS KSFM, Myin-Germeys I, Gayer-Anderson C, Kempton MJ, et al
    Elucidating negative symptoms in the daily life of individuals in the early stages of psychosis.
    Psychol Med. 2020 May 22:1-11. doi: 10.1017/S0033291720001154.
    PubMed     Abstract available

  85. HARDY A, O'Driscoll C, Steel C, van der Gaag M, et al
    A network analysis of post-traumatic stress and psychosis symptoms.
    Psychol Med. 2020 May 18:1-8. doi: 10.1017/S0033291720001300.
    PubMed     Abstract available

  86. COX ER, Marwick KFM, Hunter RW, Priller J, et al
    Dialysis and plasmapheresis for schizophrenia: a systematic review.
    Psychol Med. 2020 May 14:1-8. doi: 10.1017/S0033291720001324.
    PubMed     Abstract available

  87. HUBL D, Michel C, Schultze-Lutter F, Hauf M, et al
    Basic symptoms and gray matter volumes of patients at clinical high risk for psychosis.
    Psychol Med. 2020 May 14:1-9. doi: 10.1017/S0033291720001282.
    PubMed     Abstract available

  88. MARTIN-SUBERO M, Fuentes-Claramonte P, Salgado-Pineda P, Salavert J, et al
    Autobiographical memory and default mode network function in schizophrenia: an fMRI study-CORRIGENDUM.
    Psychol Med. 2020 May 7:1. doi: 10.1017/S0033291720001361.

    April 2020
  89. CELLA M, Price T, Corboy H, Onwumere J, et al
    Cognitive remediation for inpatients with psychosis: a systematic review and meta-analysis.
    Psychol Med. 2020 Apr 30:1-15. doi: 10.1017/S0033291720000872.
    PubMed     Abstract available

  90. SAMI M, Quattrone D, Ferraro L, Tripoli G, et al
    Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls.
    Psychol Med. 2020 Apr 28:1-9. doi: 10.1017/S0033291720000847.
    PubMed     Abstract available

  91. FUENTES-CLARAMONTE P, Lopez-Araquistain L, Sarro S, Sans-Sansa B, et al
    Brain functional correlates of formal thought disorder in schizophrenia: examining the frontal/dysexecutive hypothesis.
    Psychol Med. 2020 Apr 27:1-8. doi: 10.1017/S0033291720001063.
    PubMed     Abstract available

  92. CSUKLY G, Szabo A, Polgar P, Farkas K, et al
    Fronto-thalamic structural and effective connectivity and delusions in schizophrenia: a combined DTI/DCM study.
    Psychol Med. 2020 Apr 24:1-11. doi: 10.1017/S0033291720000859.
    PubMed     Abstract available

  93. TRIPOLI G, Quattrone D, Ferraro L, Gayer-Anderson C, et al
    Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study.
    Psychol Med. 2020 Apr 24:1-11. doi: 10.1017/S003329171900357.
    PubMed     Abstract available

  94. BALLESTEROS A, Sanchez Torres AM, Lopez-Ilundain J, Mezquida G, et al
    The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory.
    Psychol Med. 2020 Apr 24:1-10. doi: 10.1017/S003329172000080.
    PubMed     Abstract available

  95. BURGER TJ, Schirmbeck F, Vermeulen JM, Quee PJ, et al
    Association between cognitive phenotype in unaffected siblings and prospective 3- and 6-year clinical outcome in their proband affected by psychosis.
    Psychol Med. 2020 Apr 15:1-11. doi: 10.1017/S0033291720000719.
    PubMed     Abstract available

  96. ZHANG T, Xu L, Chen Y, Wei Y, et al
    Conversion to psychosis in adolescents and adults: similar proportions, different predictors.
    Psychol Med. 2020 Apr 6:1-9. doi: 10.1017/S0033291720000756.
    PubMed     Abstract available

  97. BARTOLOMEO LA, Chapman HC, Raugh IM, Strauss GP, et al
    Delay discounting in youth at clinical high-risk for psychosis and adults with schizophrenia.
    Psychol Med. 2020 Apr 6:1-8. doi: 10.1017/S0033291720000677.
    PubMed     Abstract available

  98. SALLIS HM, Croft J, Havdahl A, Jones HJ, et al
    Genetic liability to schizophrenia is associated with exposure to traumatic events in childhood.
    Psychol Med. 2020 Apr 1:1-8. doi: 10.1017/S0033291720000537.
    PubMed     Abstract available

  99. ZACHAR P, First MB, Kendler KS
    The DSM-5 proposal for attenuated psychosis syndrome: a history.
    Psychol Med. 2020 Apr 1:1-7. doi: 10.1017/S0033291720000653.
    PubMed     Abstract available

    March 2020
  100. QUATTRONE D, Ferraro L, Tripoli G, La Cascia C, et al
    Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
    Psychol Med. 2020 Mar 18:1-9. doi: 10.1017/S0033291720000082.
    PubMed     Abstract available

  101. RAUSCHENBERG C, Reininghaus U, Ten Have M, de Graaf R, et al
    The jumping to conclusions reasoning bias as a cognitive factor contributing to psychosis progression and persistence: findings from NEMESIS-2.
    Psychol Med. 2020 Mar 16:1-8. doi: 10.1017/S0033291720000446.
    PubMed     Abstract available

  102. KOWALCZYK OS, Pauls AM, Fuste M, Williams SCR, et al
    Neurocognitive correlates of working memory and emotional processing in postpartum psychosis: an fMRI study.
    Psychol Med. 2020 Mar 16:1-9. doi: 10.1017/S0033291720000471.
    PubMed     Abstract available

  103. FAGERLUND B, Pantelis C, Jepsen JRM, Raghava JM, et al
    Differential effects of age at illness onset on verbal memory functions in antipsychotic-naive schizophrenia patients aged 12-43 years.
    Psychol Med. 2020 Mar 11:1-11. doi: 10.1017/S0033291720000409.
    PubMed     Abstract available

  104. NEUMANN SR, Glue P, Linscott RJ
    Aberrant salience and reward processing: a comparison of measures in schizophrenia and anxiety.
    Psychol Med. 2020 Mar 9:1-9. doi: 10.1017/S0033291720000264.
    PubMed     Abstract available

  105. KING M, Jones R, Petersen I, Hamilton F, et al
    Cigarette smoking as a risk factor for schizophrenia or all non-affective psychoses.
    Psychol Med. 2020 Mar 9:1-9. doi: 10.1017/S0033291720000136.
    PubMed     Abstract available

  106. JONGSMA HE, Gayer-Anderson C, Tarricone I, Velthorst E, et al
    Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study.
    Psychol Med. 2020 Mar 3:1-13. doi: 10.1017/S003329172000029.
    PubMed     Abstract available

  107. CUESTA MJ, Lecumberri P, Moreno-Izco L, Lopez-Ilundain JM, et al
    Motor abnormalities and basal ganglia in first-episode psychosis (FEP).
    Psychol Med. 2020 Mar 2:1-12. doi: 10.1017/S0033291720000343.
    PubMed     Abstract available

  108. OHI K, Otowa T, Shimada M, Sasaki T, et al
    Shared genetic etiology between anxiety disorders and psychiatric and related intermediate phenotypes.
    Psychol Med. 2020;50:692-704.
    PubMed     Abstract available

    February 2020
  109. AYESA-ARRIOLA R, Ortiz-Garcia de la Foz V, Martinez-Garcia O, Setien-Suero E, et al
    Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort - CORRIGENDUM.
    Psychol Med. 2020 Feb 21:1. doi: 10.1017/S0033291719003854.

  110. COLIZZI M, Ruggeri M, Lasalvia A
    Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review.
    Psychol Med. 2020 Feb 17:1-22. doi: 10.1017/S0033291720000148.
    PubMed     Abstract available

  111. WEARNE TA, McDonald S
    Social cognition v. emotional intelligence in first-episode psychosis: are they the same?
    Psychol Med. 2020 Feb 10:1-2. doi: 10.1017/S0033291720000185.

  112. OSBORNE KJ, Damme KSF, Gupta T, Dean DJ, et al
    Timing dysfunction and cerebellar resting state functional connectivity abnormalities in youth at clinical high-risk for psychosis.
    Psychol Med. 2020 Feb 3:1-10. doi: 10.1017/S0033291719004161.
    PubMed     Abstract available

    January 2020
  113. O'NEILL A, Wilson R, Blest-Hopley G, Annibale L, et al
    Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
    Psychol Med. 2020 Jan 29:1-11. doi: 10.1017/S0033291719003519.
    PubMed     Abstract available

  114. VAN LEEUWEN JMC, Vinkers CH, Vink M, Kahn RS, et al
    Disrupted upregulation of salience network connectivity during acute stress in siblings of schizophrenia patients.
    Psychol Med. 2020 Jan 16:1-11. doi: 10.1017/S0033291719004033.
    PubMed     Abstract available

  115. GUO JY, Lesh TA, Niendam TA, Ragland JD, et al
    Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects.
    Psychol Med. 2020 Jan 8:1-10. doi: 10.1017/S0033291719003969.
    PubMed     Abstract available

  116. DECROSS SN, Farabaugh AH, Holmes AJ, Ward M, et al
    Increased amygdala-visual cortex connectivity in youth with persecutory ideation.
    Psychol Med. 2020;50:273-283.
    PubMed     Abstract available

    December 2019
  117. PINKHAM AE, Sasson NJ
    The benefit of directly comparing autism and schizophrenia, revisited.
    Psychol Med. 2019 Dec 20:1-3. doi: 10.1017/S0033291719003635.

  118. POKORNY VJ, Lano TJ, Schallmo MP, Olman CA, et al
    Reduced influence of perceptual context in schizophrenia: behavioral and neurophysiological evidence.
    Psychol Med. 2019 Dec 20:1-9. doi: 10.1017/S0033291719003751.
    PubMed     Abstract available

  119. NKIRE N, Scully PJ, Browne DJ, Baldwin PA, et al
    Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
    Psychol Med. 2019 Dec 20:1-10. doi: 10.1017/S0033291719003520.
    PubMed     Abstract available

  120. MORITZ S, Gaweda L, Heinz A, Gallinat J, et al
    Early detection. A defense of our statement that we should not catastrophize a future we cannot reliably predict nor change. A plea for a faster transition of traditional 'early intervention' programs for psychosis into new treatment models.
    Psychol Med. 2019 Dec 20:1-4. doi: 10.1017/S0033291719003477.

  121. VIEIRA S, Gong Q, Scarpazza C, Lui S, et al
    Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis.
    Psychol Med. 2019 Dec 20:1-11. doi: 10.1017/S0033291719003568.
    PubMed     Abstract available

  122. COHEN A, Morgan C
    Estimating the incidence of psychosis in diverse settings.
    Psychol Med. 2019 Dec 17:1-2. doi: 10.1017/S0033291719003702.

  123. HERBENER ES, Harrow M
    Course and symptom and functional correlates of passivity symptoms in schizophrenia: an 18-year multi-follow-up longitudinal study.
    Psychol Med. 2019 Dec 16:1-8. doi: 10.1017/S0033291719003428.
    PubMed     Abstract available

  124. ZHANG T, Xu L, Li H, Woodberry KA, et al
    Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program.
    Psychol Med. 2019 Dec 16:1-8. doi: 10.1017/S003329171900360.
    PubMed     Abstract available

  125. HJORTHOJ C, Larsen MO, Starzer MSK, Nordentoft M, et al
    Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016.
    Psychol Med. 2019 Dec 16:1-6. doi: 10.1017/S0033291719003532.
    PubMed     Abstract available

  126. LIU Y, Mendonca M, Johnson S, O'Reilly H, et al
    Testing the neurodevelopmental, trauma and developmental risk factor models of psychosis using a naturalistic experiment.
    Psychol Med. 2019 Dec 9:1-10. doi: 10.1017/S0033291719003349.
    PubMed     Abstract available

  127. HJORTHOJ C, Uddin MJ, Wimberley T, Dalsgaard S, et al
    No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder.
    Psychol Med. 2019 Dec 9:1-6. doi: 10.1017/S0033291719003362.
    PubMed     Abstract available

    November 2019
  128. RABALLO A, Poletti M
    Overlooking the transition elephant in the ultra-high-risk room: are we missing functional equivalents of transition to psychosis?
    Psychol Med. 2019 Nov 29:1-4. doi: 10.1017/S0033291719003337.
    PubMed     Abstract available

  129. CRESPI B
    How is quantification of social deficits useful for studying autism and schizophrenia?
    Psychol Med. 2019 Nov 22:1-3. doi: 10.1017/S0033291719003180.

  130. ODUOLA S, Das-Munshi J, Bourque F, Gayer-Anderson C, et al
    Change in incidence rates for psychosis in different ethnic groups in south London: findings from the Clinical Record Interactive Search-First Episode Psychosis (CRIS-FEP) study.
    Psychol Med. 2019 Nov 19:1-10. doi: 10.1017/S0033291719003234.
    PubMed     Abstract available

  131. AYESA-ARRIOLA R, Ortiz-Garcia de la Foz V, Martinez-Garcia O, Setien-Suero E, et al
    Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort.
    Psychol Med. 2019 Nov 18:1-14. doi: 10.1017/S0033291719003179.
    PubMed     Abstract available

  132. WOOTTON RE, Richmond RC, Stuijfzand BG, Lawn RB, et al
    Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study.
    Psychol Med. 2019 Nov 6:1-9. doi: 10.1017/S0033291719002678.
    PubMed     Abstract available

  133. MARTIN-SUBERO M, Fuentes-Claramonte P, Salgado-Pineda P, Salavert J, et al
    Autobiographical memory and default mode network function in schizophrenia: an fMRI study.
    Psychol Med. 2019 Nov 4:1-8. doi: 10.1017/S0033291719003052.
    PubMed     Abstract available

    October 2019
  134. BRUCATO G, First MB, Dishy GA, Samuel SS, et al
    Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients.
    Psychol Med. 2019 Oct 29:1-9. doi: 10.1017/S0033291719003040.
    PubMed     Abstract available

  135. GONZALEZ-ORTEGA I, Gonzalez-Pinto A, Alberich S, Echeburua E, et al
    Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis.
    Psychol Med. 2019 Oct 22:1-9. doi: 10.1017/S0033291719002794.
    PubMed     Abstract available

  136. SIAFIS S, Deste G, Ceraso A, Mussoni C, et al
    Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2019 Oct 18:1-12. doi: 10.1017/S003329171900285.
    PubMed     Abstract available

  137. D'SOUZA DC, Ganesh S, Cortes-Briones J, Campbell MH, et al
    Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    Psychol Med. 2019 Oct 16:1-8. doi: 10.1017/S0033291719002721.
    PubMed     Abstract available

  138. WONG TY, Radua J, Pomarol-Clotet E, Salvador R, et al
    An overlapping pattern of cerebral cortical thinning is associated with both positive symptoms and aggression in schizophrenia via the ENIGMA consortium.
    Psychol Med. 2019 Oct 16:1-12. doi: 10.1017/S0033291719002149.
    PubMed     Abstract available

  139. CHANG WC, Westbrook A, Strauss GP, Chu AOK, et al
    Abnormal cognitive effort allocation and its association with amotivation in first-episode psychosis.
    Psychol Med. 2019 Oct 2:1-11. doi: 10.1017/S0033291719002769.
    PubMed     Abstract available

  140. PINKHAM AE, Morrison KE, Penn DL, Harvey PD, et al
    Comprehensive comparison of social cognitive performance in autism spectrum disorder and schizophrenia.
    Psychol Med. 2019 Oct 2:1-9. doi: 10.1017/S0033291719002708.
    PubMed     Abstract available

    September 2019
  141. PEREZ J, Jones PB
    Breaking the web: life beyond the at-risk mental state for psychosis.
    Psychol Med. 2019 Sep 30:1-6. doi: 10.1017/S0033291719002605.
    PubMed     Abstract available

  142. VASSOS E, Sham P, Kempton M, Trotta A, et al
    The Maudsley environmental risk score for psychosis.
    Psychol Med. 2019 Sep 19:1-8. doi: 10.1017/S0033291719002319.
    PubMed     Abstract available

  143. QUATTRONE D, Richards A, Reininghaus U, Vassos E, et al
    Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis?
    Psychol Med. 2019 Sep 19:1-4. doi: 10.1017/S0033291719002435.

  144. EDWARDS CJ, Garety P, Hardy A
    The relationship between depressive symptoms and negative symptoms in people with non-affective psychosis: a meta-analysis.
    Psychol Med. 2019 Sep 18:1-13. doi: 10.1017/S0033291719002381.
    PubMed     Abstract available

  145. HERNIMAN SE, Allott K, Phillips LJ, Wood SJ, et al
    Depressive psychopathology in first-episode schizophrenia spectrum disorders: a systematic review, meta-analysis and meta-regression.
    Psychol Med. 2019 Sep 16:1-12. doi: 10.1017/S0033291719002344.
    PubMed     Abstract available

  146. BOJESEN KB, Ebdrup BH, Jessen K, Sigvard A, et al
    Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naive patients with psychosis.
    Psychol Med. 2019 Sep 16:1-12. doi: 10.1017/S0033291719002277.
    PubMed     Abstract available

  147. GUO JY, Niendam TA, Auther AM, Carrion RE, et al
    Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Psychol Med. 2019 Sep 11:1-10. doi: 10.1017/S0033291719002332.
    PubMed     Abstract available

  148. DWYER K, David AS, McCarthy R, McKenna P, et al
    Linguistic alignment and theory of mind impairments in schizophrenia patients' dialogic interactions.
    Psychol Med. 2019 Sep 10:1-9. doi: 10.1017/S0033291719002289.
    PubMed     Abstract available

    August 2019
  149. WAGGERSHAUSER M, Steinert T
    Breakthrough psychosis under antipsychotic maintenance treatment and social stress.
    Psychol Med. 2019 Aug 29:1-2. doi: 10.1017/S003329171900206.

  150. SMART SE, Kepinska AP, Murray RM, MacCabe JH, et al
    Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies.
    Psychol Med. 2019 Aug 29:1-10. doi: 10.1017/S0033291719002083.
    PubMed     Abstract available

  151. WORTINGER LA, Engen K, Barth C, Lonning V, et al
    Obstetric complications and intelligence in patients on the schizophrenia-bipolar spectrum and healthy participants.
    Psychol Med. 2019 Aug 28:1-9. doi: 10.1017/S0033291719002046.
    PubMed     Abstract available

  152. MAKOWSKI C, Lewis JD, Lepage C, Malla AK, et al
    Intersection of verbal memory and expressivity on cortical contrast and thickness in first episode psychosis.
    Psychol Med. 2019 Aug 28:1-14. doi: 10.1017/S0033291719002071.
    PubMed     Abstract available

  153. CHANG WC, Wong CSM, Or PCF, Chu AOK, et al
    Inter-relationships among psychopathology, premorbid adjustment, cognition and psychosocial functioning in first-episode psychosis: a network analysis approach.
    Psychol Med. 2019 Aug 27:1-9. doi: 10.1017/S0033291719002113.
    PubMed     Abstract available

  154. ZHANG T, Yang S, Xu L, Tang X, et al
    Poor functional recovery is better predicted than conversion in studies of outcomes of clinical high risk of psychosis: insight from SHARP.
    Psychol Med. 2019 Aug 27:1-7. doi: 10.1017/S0033291719002174.
    PubMed     Abstract available

  155. LIZANO P, Dhaliwal K, Lutz O, Mothi SS, et al
    Trajectory of neurological examination abnormalities in antipsychotic-naive first-episode psychosis population: a 1 year follow-up study.
    Psychol Med. 2019 Aug 27:1-9. doi: 10.1017/S0033291719002162.
    PubMed     Abstract available

  156. CAKICI N, van Beveren NJM, Judge-Hundal G, Koola MM, et al
    An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis.
    Psychol Med. 2019 Aug 23:1-13. doi: 10.1017/S0033291719001995.
    PubMed     Abstract available

  157. APPIAH-KUSI E, Wilson R, Colizzi M, Foglia E, et al
    Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids.
    Psychol Med. 2019 Aug 19:1-10. doi: 10.1017/S0033291719001946.
    PubMed     Abstract available

  158. VAN OS J, Pries LK, Delespaul P, Kenis G, et al
    Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study.
    Psychol Med. 2019 Aug 15:1-14. doi: 10.1017/S003329171900196.
    PubMed     Abstract available

  159. LEI D, Pinaya WHL, van Amelsvoort T, Marcelis M, et al
    Detecting schizophrenia at the level of the individual: relative diagnostic value of whole-brain images, connectome-wide functional connectivity and graph-based metrics.
    Psychol Med. 2019 Aug 8:1-10. doi: 10.1017/S0033291719001934.
    PubMed     Abstract available

  160. MALL S, Platt JM, Temmingh H, Musenge E, et al
    The relationship between childhood trauma and schizophrenia in the Genomics of Schizophrenia in the Xhosa people (SAX) study in South Africa.
    Psychol Med. 2019 Aug 7:1-8. doi: 10.1017/S0033291719001703.
    PubMed     Abstract available

    July 2019
  161. DAZZAN P, Lappin JM, Heslin M, Donoghue K, et al
    Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis.
    Psychol Med. 2019 Jul 31:1-11. doi: 10.1017/S0033291719001399.
    PubMed     Abstract available

  162. BIGDELI TB, Nuechterlein KH, Sugar CA, Subotnik KL, et al
    Evidence of shared familial factors influencing neurocognitive endophenotypes in adult- and childhood-onset schizophrenia.
    Psychol Med. 2019 Jul 31:1-8. doi: 10.1017/S0033291719001715.
    PubMed     Abstract available

  163. HOGERZEIL SJ, van Hemert AM
    Design choices when estimating the treated incidence of schizophrenia.
    Psychol Med. 2019 Jul 26:1-2. doi: 10.1017/S0033291719001338.

  164. MORITZ S, Gaweda L, Heinz A, Gallinat J, et al
    Four reasons why early detection centers for psychosis should be renamed and their treatment targets reconsidered: we should not catastrophize a future we can neither reliably predict nor change.
    Psychol Med. 2019 Jul 24:1-7. doi: 10.1017/S0033291719001740.
    PubMed     Abstract available

  165. HARRIS MA, Shen X, Cox SR, Gibson J, et al
    Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
    Psychol Med. 2019 Jul 18:1-10. doi: 10.1017/S003329171900165.
    PubMed     Abstract available

  166. KUO SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, et al
    Transdiagnostic validity of the MATRICS Consensus Cognitive Battery across the autism-schizophrenia spectrum.
    Psychol Med. 2019 Jul 12:1-10. doi: 10.1017/S0033291719001582.
    PubMed     Abstract available

  167. TAN S, Zhu X, Fan H, Tan Y, et al
    Who will benefit from computerized cognitive remediation therapy? Evidence from a multisite randomized controlled study in schizophrenia.
    Psychol Med. 2019 Jul 12:1-11. doi: 10.1017/S0033291719001594.
    PubMed     Abstract available

  168. BORA E
    Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
    Psychol Med. 2019 Jul 9:1-9. doi: 10.1017/S0033291719001685.
    PubMed     Abstract available

  169. JOYCE DW, Averbeck BB, Frith CD, Shergill SS, et al
    Examining belief and confidence in schizophrenia - ADDENDUM.
    Psychol Med. 2019 Jul 8:1. doi: 10.1017/S0033291719001363.

  170. VAN RHEENEN TE, Cropley V, Fagerlund B, Wannan C, et al
    Cognitive reserve attenuates age-related cognitive decline in the context of putatively accelerated brain ageing in schizophrenia-spectrum disorders.
    Psychol Med. 2019 Jul 5:1-15. doi: 10.1017/S0033291719001417.
    PubMed     Abstract available

    June 2019
  171. LIU S, Li A, Liu Y, Li J, et al
    MIR137 polygenic risk is associated with schizophrenia and affects functional connectivity of the dorsolateral prefrontal cortex.
    Psychol Med. 2019 Jun 26:1-9. doi: 10.1017/S0033291719001442.
    PubMed     Abstract available

  172. RUBIO JM, Taipale H, Correll CU, Tanskanen A, et al
    Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study.
    Psychol Med. 2019 Jun 13:1-12. doi: 10.1017/S0033291719001296.
    PubMed     Abstract available

  173. NAKAHARA S, Turner JA, Calhoun VD, Lim KO, et al
    Dentate gyrus volume deficit in schizophrenia.
    Psychol Med. 2019 Jun 3:1-11. doi: 10.1017/S0033291719001144.
    PubMed     Abstract available

    May 2019
    Cannabis and psychosis: revisiting a nineteenth century study of 'Indian Hemp and Insanity' in Colonial British India.
    Psychol Med. 2019 May 27:1-9. doi: 10.1017/S0033291719001077.
    PubMed     Abstract available

  175. SANDSTROM A, MacKenzie L, Pizzo A, Fine A, et al
    Observed psychopathology in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia.
    Psychol Med. 2019 May 23:1-7. doi: 10.1017/S0033291719001089.
    PubMed     Abstract available

  176. GOLD JM, Bansal S, Gaspar JM, Chen S, et al
    People with schizophrenia show enhanced cognitive costs of maintaining a single item in working memory.
    Psychol Med. 2019 May 15:1-7. doi: 10.1017/S0033291719000862.
    PubMed     Abstract available

  177. CORSI-ZUELLI F, Loureiro CM, Shuhama R, Fachim HA, et al
    Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment.
    Psychol Med. 2019 May 8:1-9. doi: 10.1017/S0033291719001016.
    PubMed     Abstract available

  178. AJNAKINA O, Stubbs B, Francis E, Gaughran F, et al
    Hospitalisation and length of hospital stay following first-episode psychosis: systematic review and meta-analysis of longitudinal studies.
    Psychol Med. 2019 May 6:1-11. doi: 10.1017/S0033291719000904.
    PubMed     Abstract available

  179. PIGNON B, Geoffroy PA, Thomas P, Roelandt JL, et al
    Environment risk factors have different impact on bipolar and psychotic disorders: an analysis of MHGP survey.
    Psychol Med. 2019;49:1229-1232.

    April 2019
  180. PLAVEN-SIGRAY P, Cervenka S
    Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears?: A commentary on 'Neuroinflammation in schizophrenia: metaanalysis of in-vivo microglial imaging' by Marques et al. - ERRATUM.
    Psychol Med. 2019 Apr 30:1-2. doi: 10.1017/S0033291719000746.

  181. LASSILA M, Nordstrom T, Hurtig T, Maki P, et al
    School success in childhood and subsequent prodromal symptoms and psychoses in the Northern Finland Birth Cohort 1986.
    Psychol Med. 2019 Apr 23:1-8. doi: 10.1017/S0033291719000825.
    PubMed     Abstract available

  182. KIRSCHNER M, Cathomas F, Manoliu A, Habermeyer B, et al
    Shared and dissociable features of apathy and reward system dysfunction in bipolar I disorder and schizophrenia.
    Psychol Med. 2019 Apr 17:1-12. doi: 10.1017/S0033291719000801.
    PubMed     Abstract available

  183. BRADLEY ER, Brustkern J, De Coster L, van den Bos W, et al
    Victory is its own reward: oxytocin increases costly competitive behavior in schizophrenia.
    Psychol Med. 2019 Apr 4:1-9. doi: 10.1017/S0033291719000552.
    PubMed     Abstract available

    March 2019
  184. OLESEN JA, Posselt CM, Poulsen CH, Nordentoft M, et al
    Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls.
    Psychol Med. 2019 Mar 18:1-8. doi: 10.1017/S0033291719000370.
    PubMed     Abstract available

  185. RYDKJAER J, Jepsen JRM, Pagsberg AK, Fagerlund B, et al
    Do young adolescents with first-episode psychosis or ADHD show sensorimotor gating deficits?
    Psychol Med. 2019 Mar 15:1-9. doi: 10.1017/S0033291719000412.
    PubMed     Abstract available

  186. GLAUSIER JR, Kelly MA, Salem S, Chen K, et al
    Proxy measures of premortem cognitive aptitude in postmortem subjects with schizophrenia.
    Psychol Med. 2019 Mar 14:1-8. doi: 10.1017/S0033291719000382.
    PubMed     Abstract available

  187. STEEN NE, Dieset I, Hope S, Vedal TSJ, et al
    Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.
    Psychol Med. 2019 Mar 14:1-12. doi: 10.1017/S0033291719000400.
    PubMed     Abstract available

  188. ISVORANU AM, Guloksuz S, Epskamp S, van Os J, et al
    Toward incorporating genetic risk scores into symptom networks of psychosis.
    Psychol Med. 2019 Mar 14:1-8. doi: 10.1017/S003329171900045.
    PubMed     Abstract available

  189. HAINING K, Matrunola C, Mitchell L, Gajwani R, et al
    Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms.
    Psychol Med. 2019 Mar 13:1-9. doi: 10.1017/S0033291718003975.
    PubMed     Abstract available

  190. CARRA G, Crocamo C, Bartoli F, Angermeyer M, et al
    The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling.
    Psychol Med. 2019 Mar 8:1-9. doi: 10.1017/S0033291719000321.
    PubMed     Abstract available

  191. WEISER M, Fenchel D, Frenkel O, Fruchter E, et al
    Understanding the association between advanced paternal age and schizophrenia and bipolar disorder.
    Psychol Med. 2019 Mar 4:1-7. doi: 10.1017/S0033291719000242.
    PubMed     Abstract available

    February 2019
  192. DI BIASE MA, Zhang F, Lyall A, Kubicki M, et al
    Neuroimaging auditory verbal hallucinations in schizophrenia patient and healthy populations.
    Psychol Med. 2019 Feb 20:1-10. doi: 10.1017/S0033291719000205.
    PubMed     Abstract available

  193. ZHANG L, Ai H, Opmeer EM, Marsman JC, et al
    Distinct temporal brain dynamics in bipolar disorder and schizophrenia during emotion regulation.
    Psychol Med. 2019 Feb 18:1-9. doi: 10.1017/S0033291719000217.
    PubMed     Abstract available

  194. JAUHAR S, Laws KR, McKenna PJ
    CBT for schizophrenia: a critical viewpoint.
    Psychol Med. 2019 Feb 13:1-4. doi: 10.1017/S0033291718004166.

  195. PLAVEN-SIGRAY P, Cervenka S
    Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears?
    Psychol Med. 2019 Feb 11:1-5. doi: 10.1017/S003329171800421.

  196. SELTEN JP, van der Ven E, Termorshuizen F
    Migration and psychosis: a meta-analysis of incidence studies.
    Psychol Med. 2019 Feb 6:1-11. doi: 10.1017/S0033291719000035.
    PubMed     Abstract available

    January 2019
  197. VAN HAREN NEM, Van Dam DS, Stellato RK
    Change in IQ in schizophrenia patients and their siblings: a controlled longitudinal study.
    Psychol Med. 2019 Jan 24:1-9. doi: 10.1017/S0033291718003537.
    PubMed     Abstract available

  198. WULFF S, Nielsen MO, Rostrup E, Svarer C, et al
    The relation between dopamine D2 receptor blockade and the brain reward system: a longitudinal study of first-episode schizophrenia patients.
    Psychol Med. 2019 Jan 15:1-9. doi: 10.1017/S0033291718004099.
    PubMed     Abstract available

  199. MCCLEERY A, Mathalon DH, Wynn JK, Roach BJ, et al
    Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm.
    Psychol Med. 2019 Jan 15:1-12. doi: 10.1017/S0033291718004087.
    PubMed     Abstract available

  200. PEH OH, Rapisarda A, Lee J
    Childhood adversities in people at ultra-high risk (UHR) for psychosis: a systematic review and meta-analysis.
    Psychol Med. 2019 Jan 8:1-13. doi: 10.1017/S003329171800394.
    PubMed     Abstract available

  201. NUECHTERLEIN KH, Subotnik KL, Ventura J, Turner LR, et al
    Enhancing return to work or school after a first episode of schizophrenia: the UCLA RCT of Individual Placement and Support and Workplace Fundamentals Module training.
    Psychol Med. 2019 Jan 4:1-9. doi: 10.1017/S0033291718003860.
    PubMed     Abstract available

  202. LAW SF, Luo X, Yao S, Wang X, et al
    Assertive Community Treatment in China - it is time for a made-in-China solution.
    Psychol Med. 2019;49:172-174.

  203. FIRN M, Alonso-Vicente M, Hubbeling D
    The Ferrari v. the bicycle.
    Psychol Med. 2019;49:170-171.

    December 2018
  204. AJNAKINA O, David AS, Murray RM
    'At risk mental state' clinics for psychosis - an idea whose time has come - and gone!
    Psychol Med. 2018 Dec 26:1-6. doi: 10.1017/S0033291718003859.
    PubMed     Abstract available

  205. BUTLER R, Berry K, Varese F, Bucci S, et al
    Are family warmth and positive remarks related to outcomes in psychosis? A systematic review.
    Psychol Med. 2018 Dec 20:1-16. doi: 10.1017/S0033291718003768.
    PubMed     Abstract available

  206. QUIDE Y, Bortolasci CC, Spolding B, Kidnapillai S, et al
    Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder.
    Psychol Med. 2018 Dec 18:1-9. doi: 10.1017/S0033291718003690.
    PubMed     Abstract available

  207. EBDRUP BH, Axelsen MC, Bak N, Fagerlund B, et al
    Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naive schizophrenia patients.
    Psychol Med. 2018 Dec 18:1-10. doi: 10.1017/S0033291718003781.
    PubMed     Abstract available

  208. DYKXHOORN J, Hollander AC, Lewis G, Magnusson C, et al
    Risk of schizophrenia, schizoaffective, and bipolar disorders by migrant status, region of origin, and age-at-migration: a national cohort study of 1.8 million people.
    Psychol Med. 2018 Dec 5:1-10. doi: 10.1017/S0033291718003227.
    PubMed     Abstract available

  209. WANNAN CMJ, Cropley VL, Chakravarty MM, Van Rheenen TE, et al
    Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder.
    Psychol Med. 2018 Dec 4:1-11. doi: 10.1017/S0033291718003458.
    PubMed     Abstract available

    November 2018
  210. KIM S, Jung WH, Howes OD, Veronese M, et al
    Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [18F]DOPA PET and fMRI study.
    Psychol Med. 2018 Nov 21:1-10. doi: 10.1017/S0033291718003471.
    PubMed     Abstract available

  211. RODRIGUEZ V, Ajnakina O, Stilo SA, Mondelli V, et al
    Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study.
    Psychol Med. 2018 Nov 5:1-11. doi: 10.1017/S0033291718003197.
    PubMed     Abstract available

    October 2018
  212. HUI CL, Honer WG, Lee EH, Chang WC, et al
    Predicting first-episode psychosis patients who will never relapse over 10 years.
    Psychol Med. 2018 Oct 30:1-9. doi: 10.1017/S0033291718003070.
    PubMed     Abstract available

  213. MARQUES TR, Ashok AH, Pillinger T, Veronese M, et al
    Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies.
    Psychol Med. 2018 Oct 25:1-11. doi: 10.1017/S0033291718003057.
    PubMed     Abstract available

  214. KRAVARITI E, Demjaha A, Zanelli J, Ibrahim F, et al
    Neuropsychological function at first episode in treatment-resistant psychosis: findings from the AESOP-10 study.
    Psychol Med. 2018 Oct 23:1-11. doi: 10.1017/S0033291718002957.
    PubMed     Abstract available

  215. ANDERSON KK, Norman R, MacDougall AG, Edwards J, et al
    Estimating the incidence of first-episode psychosis using population-based health administrative data to inform early psychosis intervention services.
    Psychol Med. 2018 Oct 12:1-9. doi: 10.1017/S0033291718002933.
    PubMed     Abstract available

  216. MALLARD TT, Harden KP, Fromme K
    Genetic risk for schizophrenia is associated with substance use in emerging adulthood: an event-level polygenic prediction model.
    Psychol Med. 2018 Oct 12:1-9. doi: 10.1017/S0033291718002817.
    PubMed     Abstract available

  217. RADHAKRISHNAN R, Guloksuz S, Ten Have M, de Graaf R, et al
    Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulation.
    Psychol Med. 2018 Oct 4:1-11. doi: 10.1017/S0033291718002635.
    PubMed     Abstract available

  218. QUATTRONE D, Di Forti M, Gayer-Anderson C, Ferraro L, et al
    Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.
    Psychol Med. 2018 Oct 4:1-14. doi: 10.1017/S0033291718002131.
    PubMed     Abstract available

  219. CASSETTA BD, Tomfohr-Madsen LM, Goghari VM
    A randomized controlled trial of working memory and processing speed training in schizophrenia.
    Psychol Med. 2018 Oct 3:1-11. doi: 10.1017/S0033291718002775.
    PubMed     Abstract available

    September 2018
  220. MATHALON DH, Roach BJ, Ferri JM, Loewy RL, et al
    Deficient auditory predictive coding during vocalization in the psychosis risk syndrome and in early illness schizophrenia: the final expanded sample.
    Psychol Med. 2018 Sep 25:1-8. doi: 10.1017/S0033291718002659.
    PubMed     Abstract available

  221. WOODROW A, Sparks S, Bobrovskaia V, Paterson C, et al
    Decision-making ability in psychosis: a systematic review and meta-analysis of the magnitude, specificity and correlates of impaired performance on the Iowa and Cambridge Gambling Tasks.
    Psychol Med. 2018 Sep 24:1-17. doi: 10.1017/S0033291718002660.
    PubMed     Abstract available

  222. PALANIYAPPAN L, Al-Radaideh A, Mougin O, Das T, et al
    Aberrant myelination of the cingulum and Schneiderian delusions in schizophrenia: a 7T magnetization transfer study.
    Psychol Med. 2018 Sep 19:1-7. doi: 10.1017/S0033291718002647.
    PubMed     Abstract available

  223. CHU AOK, Chang WC, Chan SKW, Lee EHM, et al
    Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.
    Psychol Med. 2018 Sep 18:1-8. doi: 10.1017/S0033291718002726.
    PubMed     Abstract available

  224. ZHANG T, Xu L, Tang Y, Li H, et al
    Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator.
    Psychol Med. 2018 Sep 14:1-9. doi: 10.1017/S0033291718002738.
    PubMed     Abstract available

  225. STRAUSS GP, Granholm E, Holden JL, Ruiz I, et al
    The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia.
    Psychol Med. 2018 Sep 5:1-9. doi: 10.1017/S0033291718002465.
    PubMed     Abstract available

  226. ADDINGTON J, Stowkowy J, Liu L, Cadenhead KS, et al
    Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis.
    Psychol Med. 2018 Sep 4:1-8. doi: 10.1017/S0033291718002258.
    PubMed     Abstract available

  227. DESAI M, Wooller A, Lignugaris A, Gopal S, et al
    Letter to the Editor: Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
    Psychol Med. 2018;48:2098-2099.

    August 2018
  228. RAMSAY H, Barnett JH, Murray GK, Miettunen J, et al
    Cognition, psychosis risk and metabolic measures in two adolescent birth cohorts - CORRIGENDUM.
    Psychol Med. 2018 Aug 30:1. doi: 10.1017/S0033291718002192.

  229. RABAGLIATI H, Delaney-Busch N, Snedeker J, Kuperberg G, et al
    Spared bottom-up but impaired top-down interactive effects during naturalistic language processing in schizophrenia: evidence from the visual-world paradigm.
    Psychol Med. 2018 Aug 22:1-11. doi: 10.1017/S0033291718001952.
    PubMed     Abstract available

  230. FIKSINSKI AM, Breetvelt EJ, Lee YJ, Boot E, et al
    Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia.
    Psychol Med. 2018 Aug 1:1-8. doi: 10.1017/S0033291718001824.
    PubMed     Abstract available

  231. STAFFORD J, Howard R, Kirkbride JB
    The incidence of very late-onset psychotic disorders: a systematic review and meta-analysis, 1960-2016.
    Psychol Med. 2018;48:1775-1786.
    PubMed     Abstract available

  232. DOCHERTY AR, Moscati A, Dick D, Savage JE, et al
    Polygenic prediction of the phenome, across ancestry, in emerging adulthood.
    Psychol Med. 2018;48:1814-1823.
    PubMed     Abstract available

    July 2018
  233. SO HC, Chau KL, Ao FK, Mo CH, et al
    Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits.
    Psychol Med. 2018 Jul 26:1-13. doi: 10.1017/S0033291718001812.
    PubMed     Abstract available

  234. RAMSAY H, Barnett JH, Murray GK, Miettunen J, et al
    Cognition, psychosis risk and metabolic measures in two adolescent birth cohorts.
    Psychol Med. 2018 Jul 24:1-15. doi: 10.1017/S0033291718001794.
    PubMed     Abstract available

  235. LUO X, Law SF, Wang X, Shi J, et al
    Effectiveness of an Assertive Community Treatment program for people with severe schizophrenia in mainland China - a 12-month randomized controlled trial.
    Psychol Med. 2018 Jul 2:1-11. doi: 10.1017/S0033291718001629.
    PubMed     Abstract available

  236. IKEDA M, Tanaka S, Saito T, Ozaki N, et al
    Re-evaluating classical body type theories: genetic correlation between psychiatric disorders and body mass index.
    Psychol Med. 2018;48:1745-1748.

  237. PATEL R, Chesney E, Taylor M, Taylor D, et al
    Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
    Psychol Med. 2018;48:1616-1623.
    PubMed     Abstract available

    June 2018
  238. CIARLEGLIO AJ, Brucato G, Masucci MD, Altschuler R, et al
    A predictive model for conversion to psychosis in clinical high-risk patients.
    Psychol Med. 2018 Jun 28:1-10. doi: 10.1017/S003329171800171.
    PubMed     Abstract available

  239. KRUIPER C, Fagerlund B, Nielsen MO, During S, et al
    Associations between P3a and P3b amplitudes and cognition in antipsychotic-naive first-episode schizophrenia patients.
    Psychol Med. 2018 Jun 19:1-8. doi: 10.1017/S0033291718001575.
    PubMed     Abstract available

  240. KISHI T, Ikuta T, Matsui Y, Inada K, et al
    Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.
    Psychol Med. 2018 Jun 18:1-8. doi: 10.1017/S0033291718001393.
    PubMed     Abstract available

  241. LEMMERS-JANSEN ILJ, Fett AJ, Hanssen E, Veltman DJ, et al
    Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk.
    Psychol Med. 2018 Jun 13:1-11. doi: 10.1017/S003329171800140.
    PubMed     Abstract available

  242. HARTMANN JA, Nelson B, Ratheesh A, Treen D, et al
    At-risk studies and clinical antecedents of psychosis, bipolar disorder and depression: a scoping review in the context of clinical staging.
    Psychol Med. 2018 Jun 4:1-13. doi: 10.1017/S0033291718001435.
    PubMed     Abstract available

    May 2018
  243. TAKAYANAGI Y, Sasabayashi D, Takahashi T, Komori Y, et al
    Altered brain gyrification in deficit and non-deficit schizophrenia.
    Psychol Med. 2018 May 9:1-8. doi: 10.1017/S0033291718001228.
    PubMed     Abstract available

  244. JESSEN K, Rostrup E, Mandl RCW, Nielsen MO, et al
    Cortical structures and their clinical correlates in antipsychotic-naive schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment.
    Psychol Med. 2018 May 8:1-10. doi: 10.1017/S0033291718001198.
    PubMed     Abstract available

  245. HALLGREN M, Skott M, Ekblom O, Firth J, et al
    Exercise effects on cognitive functioning in young adults with first-episode psychosis: FitForLife.
    Psychol Med. 2018 May 6:1-9. doi: 10.1017/S0033291718001022.
    PubMed     Abstract available

  246. PALANIYAPPAN L, Hodgson O, Balain V, Iwabuchi S, et al
    Structural covariance and cortical reorganisation in schizophrenia: a MRI-based morphometric study.
    Psychol Med. 2018 May 6:1-9. doi: 10.1017/S0033291718001010.
    PubMed     Abstract available

  247. LUTGENS D, Joober R, Iyer S, Lepage M, et al
    Progress of negative symptoms over the initial 5 years of a first episode of psychosis - CORRIGENDUM.
    Psychol Med. 2018 May 2:1-3. doi: 10.1017/S0033291718000843.

  248. JONSSON BH, Winzer R, Gornitzki C
    Letter to the Editor: Are older studies lost in database searches for systematic reviews?
    Psychol Med. 2018;48:1218-1219.

    April 2018
  249. MINOR KS, Willits JA, Marggraf MP, Jones MN, et al
    Measuring disorganized speech in schizophrenia: automated analysis explains variance in cognitive deficits beyond clinician-rated scales.
    Psychol Med. 2018 Apr 25:1-9. doi: 10.1017/S0033291718001046.
    PubMed     Abstract available

  250. DE JONG S, van Donkersgoed RJM, Timmerman ME, Aan Het Rot M, et al
    Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia.
    Psychol Med. 2018 Apr 25:1-11. doi: 10.1017/S0033291718000855.
    PubMed     Abstract available

  251. GUNNARSDOTTIR ED, Hallgren J, Hultman CM, McNeil TF, et al
    Risk of neurological, eye and ear disease in offspring to parents with schizophrenia or depression compared with offspring to healthy parents.
    Psychol Med. 2018 Apr 19:1-7. doi: 10.1017/S0033291718000338.
    PubMed     Abstract available

  252. KAPPELMANN N, Khandaker GM, Dal H, Stochl J, et al
    Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study.
    Psychol Med. 2018 Apr 6:1-8. doi: 10.1017/S0033291718000831.
    PubMed     Abstract available

  253. JAASKELAINEN E, Juola T, Korpela H, Lehtiniemi H, et al
    Epidemiology of psychotic depression - systematic review and meta-analysis.
    Psychol Med. 2018;48:905-918.
    PubMed     Abstract available

    March 2018
  254. BARLATI S, Deste G, Gregorelli M, Vita A, et al
    Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates.
    Psychol Med. 2018 Mar 20:1-9. doi: 10.1017/S0033291718000600.
    PubMed     Abstract available

  255. LUTGENS D, Joober R, Iyer S, Lepage M, et al
    Progress of negative symptoms over the initial 5 years of a first episode of psychosis.
    Psychol Med. 2018 Mar 14:1-9. doi: 10.1017/S003329171800048.
    PubMed     Abstract available

  256. HEUVELMAN H, Nazroo J, Rai D
    Investigating ethnic variations in reporting of psychotic symptoms: a multiple-group confirmatory factor analysis of the Psychosis Screening Questionnaire.
    Psychol Med. 2018 Mar 12:1-9. doi: 10.1017/S0033291718000399.
    PubMed     Abstract available

  257. STABLEIN M, Storchak H, Ghinea D, Kraft D, et al
    Visual working memory encoding in schizophrenia and first-degree relatives: neurofunctional abnormalities and impaired consolidation.
    Psychol Med. 2018 Mar 9:1-9. doi: 10.1017/S003329171800051.
    PubMed     Abstract available

  258. BECK AT, Himelstein R, Bredemeier K, Silverstein SM, et al
    What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors.
    Psychol Med. 2018 Mar 4:1-10. doi: 10.1017/S0033291718000442.
    PubMed     Abstract available

  259. ESCOTT-PRICE V, Smith DJ, Kendall K, Ward J, et al
    Polygenic risk for schizophrenia and season of birth within the UK Biobank cohort.
    Psychol Med. 2018 Mar 4:1-6. doi: 10.1017/S0033291718000454.
    PubMed     Abstract available

  260. WATERS F, Blom JD, Jardri R, Hugdahl K, et al
    Auditory hallucinations, not necessarily a hallmark of psychotic disorder.
    Psychol Med. 2018;48:529-536.
    PubMed     Abstract available

    February 2018
  261. FERNANDEZ-EGEA E, Worbe Y, Bernardo M, Robbins TW, et al
    Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia.
    Psychol Med. 2018 Feb 19:1-8. doi: 10.1017/S003329171800017.
    PubMed     Abstract available

  262. FERRI J, Ford JM, Roach BJ, Turner JA, et al
    Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms.
    Psychol Med. 2018 Feb 15:1-8. doi: 10.1017/S003329171800003.
    PubMed     Abstract available

  263. VANES LD, Mouchlianitis E, Collier T, Averbeck BB, et al
    Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia.
    Psychol Med. 2018 Feb 14:1-10. doi: 10.1017/S0033291718000041.
    PubMed     Abstract available

  264. BORA E, Akdede BB, Alptekin K
    The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis - CORRIGENDUM.
    Psychol Med. 2018 Feb 8:1. doi: 10.1017/S0033291717003932.

  265. BORA E
    A neurodevelopment and neuroplasticity-based framework for early intervention in psychotic disorders.
    Psychol Med. 2018;48:353-361.
    PubMed     Abstract available

  266. NYBERG J, Henriksson M, Aberg MAI, Rosengren A, et al
    Cardiovascular fitness in late adolescent males and later risk of serious non-affective mental disorders: a prospective, population-based study.
    Psychol Med. 2018;48:416-425.
    PubMed     Abstract available

    January 2018
  267. VISSER KF, Esfahlani FZ, Sayama H, Strauss GP, et al
    An ecological momentary assessment evaluation of emotion regulation abnormalities in schizophrenia.
    Psychol Med. 2018 Jan 24:1-9. doi: 10.1017/S0033291717003865.
    PubMed     Abstract available

  268. PADULA MC, Schaer M, Armando M, Sandini C, et al
    Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis.
    Psychol Med. 2018 Jan 17:1-9. doi: 10.1017/S0033291717003920.
    PubMed     Abstract available

  269. ZWICKER A, Denovan-Wright EM, Uher R
    Gene-environment interplay in the etiology of psychosis.
    Psychol Med. 2018 Jan 15:1-12. doi: 10.1017/S003329171700383.
    PubMed     Abstract available

  270. BALLESTEROS A, Sanchez-Torres AM, Lopez-Ilundain JM, Cabrera B, et al
    Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
    Psychol Med. 2018 Jan 14:1-10. doi: 10.1017/S0033291717003774.
    PubMed     Abstract available

  271. GRANT PM, Perivoliotis D, Luther L, Bredemeier K, et al
    Rapid improvement in beliefs, mood, and performance following an experimental success experience in an analogue test of recovery-oriented cognitive therapy.
    Psychol Med. 2018;48:261-268.
    PubMed     Abstract available

  272. WANNAN CMJ, Bartholomeusz CF, Cropley VL, Van Rheenen TE, et al
    Deterioration of visuospatial associative memory following a first psychotic episode: a long-term follow-up study.
    Psychol Med. 2018;48:132-141.
    PubMed     Abstract available

    December 2017
  273. KILIAN S, Asmal L, Chiliza B, Olivier MR, et al
    Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition.
    Psychol Med. 2017 Dec 22:1-8. doi: 10.1017/S0033291717003671.
    PubMed     Abstract available

  274. RIGLIN L, Collishaw S, Richards A, Thapar AK, et al
    The impact of schizophrenia and mood disorder risk alleles on emotional problems: investigating change from childhood to middle age.
    Psychol Med. 2017 Dec 14:1-6. doi: 10.1017/S0033291717003634.
    PubMed     Abstract available

  275. RANNING A, Laursen T, Agerbo E, Thorup A, et al
    School performance from primary education in the adolescent offspring of parents with schizophrenia and bipolar disorder- a national, register-based study.
    Psychol Med. 2017 Dec 14:1-8. doi: 10.1017/S0033291717003518.
    PubMed     Abstract available

  276. SILVERSTEIN SM, Paterno D, Cherneski L, Green S, et al
    Optical coherence tomography indices of structural retinal pathology in schizophrenia.
    Psychol Med. 2017 Dec 13:1-11. doi: 10.1017/S0033291717003555.
    PubMed     Abstract available

  277. HUFNER K, Brugger H, Kuster E, Dunsser F, et al
    Isolated psychosis during exposure to very high and extreme altitude - characterisation of a new medical entity.
    Psychol Med. 2017 Dec 5:1-8. doi: 10.1017/S0033291717003397.
    PubMed     Abstract available

    November 2017
  278. OKRUSZEK L, Wordecha M, Jarkiewicz M, Kossowski B, et al
    Brain correlates of recognition of communicative interactions from biological motion in schizophrenia.
    Psychol Med. 2017 Nov 27:1-10. doi: 10.1017/S0033291717003385.
    PubMed     Abstract available

  279. ZHANG T, Xu L, Tang Y, Cui H, et al
    Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome.
    Psychol Med. 2017 Nov 27:1-8. doi: 10.1017/S0033291717002707.
    PubMed     Abstract available

  280. ALLOTT K, Fraguas D, Bartholomeusz CF, Diaz-Caneja CM, et al
    Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis.
    Psychol Med. 2017 Nov 27:1-18. doi: 10.1017/S0033291717003002.
    PubMed     Abstract available

  281. BLAKEY R, Ranlund S, Zartaloudi E, Cahn W, et al
    Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains.
    Psychol Med. 2017 Nov 2:1-20. doi: 10.1017/S0033291717002860.
    PubMed     Abstract available

    October 2017
  282. ZOGHBI AW, Lieberman JA
    Alive but not well: the limited validity but continued utility of the concept of schizophrenia.
    Psychol Med. 2017 Oct 26:1-2. doi: 10.1017/S0033291717001969.
    PubMed     Abstract available

  283. KAHN RS
    Why the concept of schizophrenia is still alive and kicking.
    Psychol Med. 2017 Oct 26:1-2. doi: 10.1017/S0033291717002069.

  284. NEILSON E, Bois C, Clarke TK, Hall L, et al
    Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study.
    Psychol Med. 2017 Oct 25:1-11. doi: 10.1017/S0033291717003087.
    PubMed     Abstract available

  285. MUCCI A, Galderisi S, Green MF, Nuechterlein K, et al
    Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Psychol Med. 2017 Oct 11:1-10. doi: 10.1017/S0033291717002902.
    PubMed     Abstract available

  286. XIE DJ, Lui SSY, Geng FL, Yang ZY, et al
    Dissociation between affective experience and motivated behaviour in schizophrenia patients and their unaffected first-degree relatives and schizotypal individuals.
    Psychol Med. 2017 Oct 11:1-13. doi: 10.1017/S0033291717002926.
    PubMed     Abstract available

  287. AAS M, Melle I, Bettella F, Djurovic S, et al
    Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not.
    Psychol Med. 2017 Oct 2:1-7. doi: 10.1017/S0033291717001209.
    PubMed     Abstract available

    September 2017
  288. LU Y, Pouget JG, Andreassen OA, Djurovic S, et al
    Genetic risk scores and family history as predictors of schizophrenia in Nordic registers.
    Psychol Med. 2017 Sep 25:1-9. doi: 10.1017/S0033291717002665.
    PubMed     Abstract available

  289. DONOHOE G, Dillon R, Hargreaves A, Mothersill O, et al
    Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial.
    Psychol Med. 2017 Sep 21:1-14. doi: 10.1017/S0033291717001982.
    PubMed     Abstract available

  290. GAUGHRAN F, Lally J, Beck K, McCormack R, et al
    Brain-relevant antibodies in first-episode psychosis: a matched case-control study.
    Psychol Med. 2017 Sep 18:1-9. doi: 10.1017/S0033291717002689.
    PubMed     Abstract available

  291. TIN LNW, Lui SSY, Ho KKY, Hung KSY, et al
    High-functioning autism patients share similar but more severe impairments in verbal theory of mind than schizophrenia patients.
    Psychol Med. 2017 Sep 18:1-12. doi: 10.1017/S0033291717002690.
    PubMed     Abstract available

  292. CULBRETH AJ, Moran EK, Barch DM
    Effort-cost decision-making in psychosis and depression: could a similar behavioral deficit arise from disparate psychological and neural mechanisms?
    Psychol Med. 2017 Sep 11:1-16. doi: 10.1017/S0033291717002525.
    PubMed     Abstract available

  293. SCHULTZE-LUTTER F, Michel C, Ruhrmann S, Schimmelmann BG, et al
    Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community.
    Psychol Med. 2017 Sep 11:1-15. doi: 10.1017/S0033291717002586.
    PubMed     Abstract available

  294. REEDER C, Huddy V, Cella M, Taylor R, et al
    A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial.
    Psychol Med. 2017 Sep 4:1-11. doi: 10.1017/S0033291717001234.
    PubMed     Abstract available

    August 2017
  295. CURTIS D, Derks EM
    Letter to the Editor: Schizophrenia does not represent the extreme of a normally distributed trait.
    Psychol Med. 2017 Aug 29:1-2. doi: 10.1017/S0033291717002422.

  296. BORA E
    Letter to the Editor: The half-alive concept of schizophrenia is still better than the spectrum of everything.
    Psychol Med. 2017 Aug 29:1-2. doi: 10.1017/S0033291717002446.

  297. LEROY A, Petyt G, Pignon B, Vaiva G, et al
    Research Letter: Auto-activation deficit in schizophrenia: a case report.
    Psychol Med. 2017 Aug 24:1-3. doi: 10.1017/S0033291717002252.

  298. DEGNAN A, Baker S, Edge D, Nottidge W, et al
    The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2017 Aug 23:1-14. doi: 10.1017/S0033291717002264.
    PubMed     Abstract available

  299. SERPA MH, Doshi J, Erus G, Chaim-Avancini TM, et al
    State-dependent microstructural white matter changes in drug-naive patients with first-episode psychosis.
    Psychol Med. 2017 Aug 22:1-15. doi: 10.1017/S0033291717001015.
    PubMed     Abstract available

  300. DIMITRAKOPOULOS S, Vitoratou S, Mougiakos T, Bogeas N, et al
    Steinberg and Durell (1968) revisited: increased rates of First Episode Psychosis following military induction in Greek Army Recruits.
    Psychol Med. 2017 Aug 22:1-9. doi: 10.1017/S0033291717002276.
    PubMed     Abstract available

  301. BOUSMAN CA, Cropley V, Klauser P, Hess JL, et al
    Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.
    Psychol Med. 2017 Aug 22:1-9. doi: 10.1017/S0033291717002173.
    PubMed     Abstract available

  302. CURTIS D
    Association between smoking and psychosis may be mediated by maternal smoking during pregnancy.
    Psychol Med. 2017 Aug 14:1. doi: 10.1017/S0033291717002240.

  303. HUANG X, Fox KR, Ribeiro JD, Franklin JC, et al
    Psychosis as a risk factor for suicidal thoughts and behaviors: a meta-analysis of longitudinal studies.
    Psychol Med. 2017 Aug 14:1-12. doi: 10.1017/S0033291717002136.
    PubMed     Abstract available

  304. REICHERT A, Jacobs R
    Socioeconomic inequalities in duration of untreated psychosis: evidence from administrative data in England.
    Psychol Med. 2017 Aug 14:1-12. doi: 10.1017/S0033291717002197.
    PubMed     Abstract available

    July 2017
  305. RUS-CALAFELL M, Garety P, Sason E, Craig TJK, et al
    Virtual reality in the assessment and treatment of psychosis: a systematic review of its utility, acceptability and effectiveness.
    Psychol Med. 2017 Jul 24:1-30. doi: 10.1017/S0033291717001945.
    PubMed     Abstract available

  306. MOLLON J, Reichenberg A
    Cognitive development prior to onset of psychosis.
    Psychol Med. 2017 Jul 24:1-12. doi: 10.1017/S0033291717001970.
    PubMed     Abstract available

  307. DREIER JW, Berg-Beckhoff G, Andersen AMN, Susser E, et al
    Fever and infections during pregnancy and psychosis-like experiences in the offspring at age 11. A prospective study within the Danish National Birth Cohort.
    Psychol Med. 2017 Jul 24:1-11. doi: 10.1017/S0033291717001805.
    PubMed     Abstract available

  308. FIRTH J, Stubbs B, Sarris J, Rosenbaum S, et al
    The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis - CORRIGENDUM.
    Psychol Med. 2017 Jul 17:1. doi: 10.1017/S0033291717001866.

  309. JEPSEN JRM, Rydkjaer J, Fagerlund B, Pagsberg AK, et al
    Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder.
    Psychol Med. 2017 Jul 17:1-13. doi: 10.1017/S0033291717001921.
    PubMed     Abstract available

  310. GULOKSUZ S, van Os J
    The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum.
    Psychol Med. 2017 Jul 10:1-16. doi: 10.1017/S0033291717001775.
    PubMed     Abstract available

    June 2017
  311. PAKSARIAN D, Trabjerg BB, Merikangas KR, Mors O, et al
    The role of genetic liability in the association of urbanicity at birth and during upbringing with schizophrenia in Denmark.
    Psychol Med. 2017 Jun 29:1-10. doi: 10.1017/S0033291717001696.
    PubMed     Abstract available

  312. CUI Y, Liu B, Song M, Lipnicki DM, et al
    Auditory verbal hallucinations are related to cortical thinning in the left middle temporal gyrus of patients with schizophrenia.
    Psychol Med. 2017 Jun 19:1-8. doi: 10.1017/S0033291717001520.
    PubMed     Abstract available

  313. BORA E, Ozerdem A
    Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia.
    Psychol Med. 2017 Jun 6:1-14. doi: 10.1017/S0033291717001490.
    PubMed     Abstract available

    May 2017
  314. WALTON E, Hibar DP, van Erp TGM, Potkin SG, et al
    Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium.
    Psychol Med. 2017 May 26:1-13. doi: 10.1017/S0033291717001283.
    PubMed     Abstract available

  315. ZHENG W, Li XH, Yang XH, Cai DB, et al
    Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Psychol Med. 2017 May 22:1-10. doi: 10.1017/S0033291717001271.
    PubMed     Abstract available

  316. DI BIASE MA, Cropley VL, Baune BT, Olver J, et al
    White matter connectivity disruptions in early and chronic schizophrenia.
    Psychol Med. 2017 May 22:1-14. doi: 10.1017/S0033291717001313.
    PubMed     Abstract available

  317. MORITZ S, Klein JP, Desler T, Lill H, et al
    Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills?
    Psychol Med. 2017 May 9:1-11. doi: 10.1017/S0033291717000939.
    PubMed     Abstract available

  318. BORA E, Binnur Akdede B, Alptekin K
    Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis.
    Psychol Med. 2017 May 4:1-14. doi: 10.1017/S0033291717000952.
    PubMed     Abstract available

  319. KRAKAUER K, Ebdrup BH, Glenthoj BY, Raghava JM, et al
    Patterns of white matter microstructure in individuals at ultra-high-risk for psychosis: associations to level of functioning and clinical symptoms.
    Psychol Med. 2017 May 3:1-19. doi: 10.1017/S0033291717001210.
    PubMed     Abstract available

  320. ALDERSON HL, Semple DM, Blayney C, Queirazza F, et al
    Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study.
    Psychol Med. 2017 May 3:1-8. doi: 10.1017/S0033291717001118.
    PubMed     Abstract available

  321. LEES J, Michalopoulou PG, Lewis SW, Preston S, et al
    Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.
    Psychol Med. 2017 May 3:1-11. doi: 10.1017/S0033291717000885.
    PubMed     Abstract available

    April 2017
  322. ORANJE B, Aggernaes B, Rasmussen H, Ebdrup BH, et al
    Selective attention and mismatch negativity in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy.
    Psychol Med. 2017 Apr 26:1-11. doi: 10.1017/S0033291717000599.
    PubMed     Abstract available

  323. PAN YJ, Yeh LL, Chan HY, Chang CK, et al
    Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan.
    Psychol Med. 2017 Apr 26:1-11. doi: 10.1017/S0033291717001040.
    PubMed     Abstract available

  324. SPENCER BWJ, Shields G, Gergel T, Hotopf M, et al
    Diversity or disarray? A systematic review of decision-making capacity for treatment and research in schizophrenia and other non-affective psychoses.
    Psychol Med. 2017 Apr 26:1-17. doi: 10.1017/S0033291717000502.
    PubMed     Abstract available

  325. PARELLADA M, Pina-Camacho L, Moreno C, Aleman Y, et al
    Insular pathology in young people with high-functioning autism and first-episode psychosis.
    Psychol Med. 2017 Apr 24:1-11. doi: 10.1017/S0033291717000988.
    PubMed     Abstract available

  326. OUELLET-PLAMONDON C, Abdel-Baki A, Salvat E, Potvin S, et al
    Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Psychol Med. 2017 Apr 20:1-11. doi: 10.1017/S0033291717000976.
    PubMed     Abstract available

  327. VERMEULEN J, van Rooijen G, Doedens P, Numminen E, et al
    Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.
    Psychol Med. 2017 Apr 11:1-12. doi: 10.1017/S0033291717000873.
    PubMed     Abstract available

  328. DEMJAHA A, Lappin JM, Stahl D, Patel MX, et al
    Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
    Psychol Med. 2017 Apr 11:1-9. doi: 10.1017/S0033291717000435.
    PubMed     Abstract available

  329. KNAPP F, Viechtbauer W, Leonhart R, Nitschke K, et al
    Planning performance in schizophrenia patients: a meta-analysis of the influence of task difficulty and clinical and sociodemographic variables.
    Psychol Med. 2017 Apr 7:1-15. doi: 10.1017/S0033291717000459.
    PubMed     Abstract available

  330. CHIEN WT, Bressington D, Yip A, Karatzias T, et al
    An international multi-site, randomized controlled trial of a mindfulness-based psychoeducation group programme for people with schizophrenia.
    Psychol Med. 2017 Apr 4:1-16. doi: 10.1017/S0033291717000526.
    PubMed     Abstract available

    March 2017
  331. EMSLEY R, Asmal L, du Plessis S, Chiliza B, et al
    Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
    Psychol Med. 2017 Mar 28:1-10. doi: 10.1017/S0033291717000642.
    PubMed     Abstract available

  332. TEMPELAAR WM, Termorshuizen F, MacCabe JH, Boks MP, et al
    Educational achievement in psychiatric patients and their siblings: a register-based study in 30 000 individuals in The Netherlands.
    Psychol Med. 2017;47:776-784.
    PubMed     Abstract available

  333. AAS M, Kauppi K, Brandt CL, Tesli M, et al
    Childhood trauma is associated with increased brain responses to emotionally negative as compared with positive faces in patients with psychotic disorders.
    Psychol Med. 2017;47:669-679.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.